Search Browse Earnings

Lexeo Therapeutics, Inc. — SlamSEC

Lexeo Therapeutics, Inc.

Nasdaq:LXEO

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$654,000

FY 2023

Adj. EBITDA

-$68.2M

-10434.6% margin

FY 2024

Net Income

-$66.4M

-10152.0% margin

FY 2024

EPS (Diluted)

-$12.40

FY 2024

Stock Price

$7.42

+8.4%

2026-03-09

52W Range

$1.45 – $10.99

P/E Ratio

-0.6x

Market Cap

$541.9M

Cash

$121.5M

FY 2024

Total Debt

—

Net Cash

$121.5M

FY 2023

Enterprise Value

$420.4M

Debt / EBITDA

1.8x

FY 2023

EV / EBITDA

-6.2x

Employees

—